Recommendation: Add; Target Price: Rs 2625
Following IIFL’s January 2023 recommendation downgrade on Dr. Reddy’s Labs (Dr. Reddy’s), analysts at IIFL Capital Services have further cut their rating to Reduce (from Add). The stock’s 15% rally YTD seems to be out of sync with continued muted trends on the base business (ex-Revlimid).
Recommendation: Buy; Target Price: Rs 555
Recommendation: Buy; Target Price: Rs 2558
Recommendation: Reduce; Target Price: Rs 680
Recommendation: Buy; Target Price: Rs 580
Tyre industry has not been a high volume growth story. Long-term volume growth has only been about 6% and revenue CAGR slightly higher than volumes.
Recommendation: Add; Target Price: Rs 720
Recommendation: Reduce; Target Price: Rs 1800
Recommendation: Add; Target Price: Rs 410
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
